MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$137,885K
Free Cash flow
-$116,595K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Share-based compensation expense
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Purchase of marketable securitie...
Net loss
Purchases of property and equipm...
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2026-04-30
Net loss
-131,612
Depreciation and amortization
8,709
Loss on disposal of property and equipment
-1,161
Reserve for equipment and supplies
2,435
Provision for uncollectible accounts receivable
2,596
Amortization (accretion) of premiums (discounts) on securities, net
106
Amortization of debt discounts and issuance costs
1,874
Share-based compensation expense
33,644
Non-cash lease expense
326
Deferred income tax expense
166
Change in fair value of warrant liabilities
-2,673
Disposable medical equipment supplies
-458
Prepaid expenses and other current assets
563
Accounts receivable
9,056
Accounts payable
4,302
Accrued liabilities
8,197
Operating lease liabilities
-685
Other long-term assets
-40
Net cash used in operating activities
-81,703
Purchases of property and equipment
34,892
Deposits for medical rental equipment
528
Refund of deposits for medical rental equipment
184
Investment in equity security
5,000
Purchase of marketable securities
163,041
Net cash used in investing activities
-203,277
Proceeds from issuance of common stock
149,291
Payment of equity issuance costs
2,466
Deemed dividend for payments to third party on behalf of shareholder
323
Proceeds from stock option exercises
593
Net cash provided by financing activities
147,095
Net increase (decrease) in cash, cash equivalents and restricted cash
-137,885
Beginning of period
237,929
End of period
100,044
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock
$149,291K
Proceeds from stock
option exercises
$593K
Net cash provided by
financing activities
$147,095K
Canceled cashflow
$2,789K
Net increase
(decrease) in cash, cash...
-$137,885K
Canceled cashflow
$147,095K
Refund of deposits for
medical rental...
$184K
Share-based compensation
expense
$33,644K
Depreciation and
amortization
$8,709K
Accrued liabilities
$8,197K
Accounts payable
$4,302K
Provision for
uncollectible accounts...
$2,596K
Reserve for equipment
and supplies
$2,435K
Amortization of debt
discounts and issuance...
$1,874K
Loss on disposal of
property and equipment
-$1,161K
Non-cash lease expense
$326K
Deferred income tax
expense
$166K
Other long-term
assets
-$40K
Payment of equity
issuance costs
$2,466K
Deemed dividend for
payments to third party on...
$323K
Net cash used in
investing activities
-$203,277K
Canceled cashflow
$184K
Net cash used in
operating activities
-$81,703K
Canceled cashflow
$63,450K
Purchase of marketable
securities
$163,041K
Purchases of property and
equipment
$34,892K
Investment in equity
security
$5,000K
Deposits for medical
rental equipment
$528K
Net loss
-$131,612K
Accounts receivable
$9,056K
Change in fair value of
warrant liabilities
-$2,673K
Operating lease
liabilities
-$685K
Prepaid expenses and
other current assets
$563K
Disposable medical
equipment supplies
-$458K
Amortization (accretion) of
premiums (discounts) on...
$106K
Buy us a coffee
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)